U.S. NeuroSurgical Holdings, Inc. Stock Other OTC

U.S. NeuroSurgical Holdings, Inc. owns and operates, through its wholly owned subsidiaries, stereotactic radiosurgery centers, utilizing gamma knife technology, and holds other interests in radiological treatment facilities. The Company's subsidiary, U.S. NeuroSurgical, Inc. (USN), which owns and operates stereotactic radiosurgery centers and utilizes the gamma knife technology. The Company owns, or holds interests in, the gamma knife and radiation treatment centers, and charges the hospital or medical facility, where the unit is housed and maintained, based on utilization. The Company also focused on developing cancer centers featuring radiation therapy. These centers utilize linear accelerators with Intensity Modulated Radiation Therapy (IMRT) and Image Guided Radiation Therapy (IGRT) capabilities. The Company's principal target market is medical centers in health care catchment areas that have physicians experienced with and dedicated to the use of the gamma knife.